Britain, a global leader in medical innovation, has finalised a US-UK pharmaceutical trade deal – but unless patients can access new treatments quickly and fairly, those breakthroughs risk being little more than scientific triumphs on paper, says Patrick Vallance L ast year, doctors at Moorfields Eye Hospital made a remarkable breakthrough. They saved – and dramatically improved – the sight of four toddlers who had a rare genetic condition that would have left them blind for life . It was